Dr. Jason Wilson revisits the use of fluvoxamine in the treatment of Covid-19. He discusses an exciting study recently published in Lancet Global Health that may change how doctors are treating Covid-19.
Read More
Dr. Okonkwo talks about the arrival and safety of the Covid-19 vaccine. Hear how several of our providers reacted to being among the first to receive the vaccine.
Read More
Dr. Jason Wilson discusses the ACTIV-4 trial. This trial is a part of Operation Warp Speed, a federal government funded effort to rapidly develop vaccines and therapeutic modalities to treat, prevent, or minimize side effects of Covid through the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV) protocols. ACTIV-4 investigates the use of Abixiban and Aspirin in preventing VTE in Covid-19 patients.
Read More
Dr. Jason Wilson discusses a recent, small randomized controlled trial published in JAMA which investigated the use of fluvoxamine, an SSRI, as a therapeutic treatment option for Covid. The results of the study and the proposed mechanism are quite interesting. Find out why fluvoxamine is not ready for prime time, but SSRIs may deserve funding for larger clinical studies.
Read More
No matter where you practice, one day you’ll likely be expected to manage fever in the returning traveler. In this post, Dr. Okonkwo shares a recent lecture she gave on 5 tropical infections all ER Providers should know. She also goes over the condition that was #1 on her list: Malaria. Learn more about this can’t miss diagnosis.
Read More